SYRE icon

Spyre Therapeutics
SYRE

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$60
82% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Mizuho
Mizuho
Joseph Catanzaro
100% 1-yr SYRE win rate
18 Dec ‘25 28 days ago
Citigroup
Citigroup
Samantha Semenkow
100% 1-yr SYRE win rate
17 Dec ‘25 28 days ago
Jones Trading
Jones Trading
Debanjana Chatterjee
100% 1-yr SYRE win rate
1 Dec ‘25 1 month ago